» Articles » PMID: 29138119

Thrombospondin-4 in Tissue Remodeling

Overview
Journal Matrix Biol
Publisher Elsevier
Date 2017 Nov 16
PMID 29138119
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombospondin-4 (TSP-4) belongs to the thrombospondin protein family that consists of five highly homologous members. A number of novel functions have been recently assigned to TSP-4 in cardiovascular and nervous systems, inflammation, cancer, and the motor unit, which have attracted attention to this extracellular matrix (ECM) protein. These newly discovered functions set TSP-4 apart from other thrombospondins. For example, TSP-4 promotes angiogenesis while other TSPs either prevent it or have no effect on new blood vessel growth; TSP-4 reduces fibrosis and collagen production while TSP-1 and TSP-2 promote fibrosis in several organs; unlike other TSPs, TSP-4 appears to have some structural functions in ECM. The current information about TSP-4 functions in different organs and physiological systems suggests that this evolutionary conserved protein is a major regulator of the extracellular matrix (ECM) organization and production and tissue remodeling during the embryonic development and response to injury. In this review article, we summarize the properties and functions of TSP-4 and discuss its role in tissue remodeling.

Citing Articles

Resistance exercise training in older men reduces ATF4-activated and senescence-associated mRNAs in skeletal muscle.

Von Ruff Z, Miller M, Moro T, Reidy P, Ebert S, Volpi E Geroscience. 2025; .

PMID: 40011348 DOI: 10.1007/s11357-025-01564-2.


Airway MMP-12 and DNA methylation in COPD: an integrative approach.

Eriksson Strom J, Merid S, Linder R, Pourazar J, Lindberg A, Melen E Respir Res. 2025; 26(1):10.

PMID: 39794761 PMC: 11724436. DOI: 10.1186/s12931-024-03088-3.


Systemic biological mechanisms underpin poor post-discharge growth among severely wasted children with HIV.

Mudibo E, Bogaert J, Tigoi C, Ngari M, Singa B, Lancioni C Nat Commun. 2024; 15(1):10299.

PMID: 39604330 PMC: 11603168. DOI: 10.1038/s41467-024-54717-w.


Thrombospondins: Conserved mediators and modulators of metazoan extracellular matrix.

Adams J Int J Exp Pathol. 2024; 105(5):136-169.

PMID: 39267379 PMC: 11574667. DOI: 10.1111/iep.12517.


Potential Targeting Mechanisms for Bone-Directed Therapies.

Celik B, Leal A, Tomatsu S Int J Mol Sci. 2024; 25(15).

PMID: 39125906 PMC: 11312506. DOI: 10.3390/ijms25158339.


References
1.
Volpert O, Tolsma S, Pellerin S, Feige J, Chen H, Mosher D . Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun. 1995; 217(1):326-32. DOI: 10.1006/bbrc.1995.2780. View

2.
Muppala S, Xiao R, Krukovets I, Verbovetsky D, Yendamuri R, Habib N . Thrombospondin-4 mediates TGF-β-induced angiogenesis. Oncogene. 2017; 36(36):5189-5198. PMC: 5589494. DOI: 10.1038/onc.2017.140. View

3.
Pan B, Guo Y, Wu H, Park J, Trinh V, Luo Z . Thrombospondin-4 divergently regulates voltage-gated Ca2+ channel subtypes in sensory neurons after nerve injury. Pain. 2016; 157(9):2068-2080. PMC: 4988923. DOI: 10.1097/j.pain.0000000000000612. View

4.
Barsby T, Bavin E, Guest D . Three-dimensional culture and transforming growth factor beta3 synergistically promote tenogenic differentiation of equine embryo-derived stem cells. Tissue Eng Part A. 2014; 20(19-20):2604-13. PMC: 4195467. DOI: 10.1089/ten.TEA.2013.0457. View

5.
Wilsgaard T, Mathiesen E, Patwardhan A, Rowe M, Schirmer H, Lochen M . Clinically significant novel biomarkers for prediction of first ever myocardial infarction: the Tromsø Study. Circ Cardiovasc Genet. 2015; 8(2):363-71. DOI: 10.1161/CIRCGENETICS.113.000630. View